Standardization of measurement of immunoglobulin-secreting cells in human peripheral circulation

S Baqar, A A Nour El Din, D A Scott, A L Bourgeois, A S Mourad, M T Kleinosky, M J Oplinger, J R Murphy, S Baqar, A A Nour El Din, D A Scott, A L Bourgeois, A S Mourad, M T Kleinosky, M J Oplinger, J R Murphy

Abstract

A sensitive, and at times the most sensitive, measurement of human vaccine immunogenicity is enumeration of antibody-secreting cells (ASC) in peripheral blood. However, this assay, which is inherently capable of measurement of the absolute number of antigen-specific ASC, is not standardized. Thus, quantitative comparison of results between laboratories is not currently possible. To address this issue, isotype-specific ASC were enumerated from paired fresh and cryopreserved mononuclear cell (MNC) preparations from healthy adult volunteers resident in either the United States (US group) or Egypt (EG group). Analysis of fresh cells from US volunteers revealed mean numbers of ASC per 10(6) MNC of 617, 7,738, and 868 for immunoglobulin M (IgM), IgG, and IgA, respectively, whereas EG volunteers had 2,086, 7,580, and 1,677 ASC/10(6) MNC for the respective isotypes. Cryopreservation resulted in a slight reduction in group mean IgM, IgG, and IgA ASC (maximum reduction in group mean, 14%), but in no instance were results obtained with cryopreserved cells significantly lower than those obtained with fresh cells. To determine if cryopreservation affected the number of bacterial antigen-specific ASC detected, cells from a group of US adult volunteers who received a single oral dose of a mutated Escherichia coli heat-labile enterotoxin (LT(R192G)) were tested. There was no significant difference (P > 0.05) in the number of antigen-specific IgA or IgG ASC detected between fresh and cryopreserved MNC. The results support the views that ASC assays can be standardized to yield quantitative results and that the methodology can be changed to make the test more practical.

References

    1. Vaccine. 1995 Jan;13(1):22-8
    1. Infect Immun. 1995 May;63(5):1617-23
    1. J Infect Dis. 1996 Jan;173(1):136-41
    1. Immunology. 1980 Oct;41(2):249-70
    1. Ann N Y Acad Sci. 1983 Jun 30;409:194-203
    1. Rev Infect Dis. 1983 Sep-Oct;5 Suppl 4:S784-92
    1. Am J Trop Med Hyg. 1986 Sep;35(5):1013-22
    1. J Clin Immunol. 1987 Jul;7(4):265-76
    1. Lancet. 1988 Jan 16;1(8577):81-3
    1. Rev Infect Dis. 1988 Jan-Feb;10(1):111-24
    1. J Infect Dis. 1988 Nov;158(5):1011-6
    1. J Oral Pathol. 1988 Nov;17(9-10):456-9
    1. Infect Immun. 1990 Jun;58(6):2002-4
    1. Vaccine. 1990 Aug;8(4):321-6
    1. J Clin Invest. 1991 Jul;88(1):143-8
    1. Eur J Immunol. 1991 Sep;21(9):2087-94
    1. J Clin Immunol. 1991 Jul;11(4):213-8
    1. J Pediatr. 1992 Jan;120(1):9-15
    1. J Immunol Methods. 1993 Apr 2;160(2):181-9
    1. J Pediatr. 1993 May;122(5 Pt 1):780-6
    1. Vaccine. 1993;11(9):929-34
    1. Clin Exp Immunol. 1994 Feb;95(2):222-6
    1. Trans R Soc Trop Med Hyg. 1993 Dec;87 Suppl 3:27-30
    1. Am J Trop Med Hyg. 1995 Jul;53(1):47-54

Source: PubMed

3
Suscribir